LGP reports sales downturn but predicts a ‘re-rating’ of Australian firms amid US rescheduling report by Steve Jones January 31, 2024July 11, 2024 Little Green Pharma (LGP) has blamed a fall in oil and flower sales on supply chain […]
Company news: Clever Leaves; Cronos/Vitura; InhaleRX; Emyria; CannMart/Aura Therapeutics; Cann Group; Greenfern Industries; LGP/Reset Mind Sciences by Steve Jones and Martin Lane January 16, 2024July 11, 2024
Flower sales surge past oil as LGP reports 53% rise in Q1 revenue by Steve Jones July 28, 2023April 30, 2024
Concern and confusion emerges again over pharmacy brand substitutions by Steve Jones July 20, 2023January 13, 2025
Company news: Little Green Pharma; Cann Group; Melodiol Global Health; Entourage Health; Levin Health by Steve Jones and Martin Lane July 12, 2023April 30, 2024
LGP chairman tells of ‘disbelief’ over fines as firm turns ‘immediate priority’ to cash flow break-even by Steve Jones July 3, 2023April 30, 2024
TGA rejects inconsistency charge amid 16 ‘active and in-depth’ advertising investigations by Steve Jones May 25, 2023April 30, 2024
Little Green Pharma reports revenue rise but operating deficit nears A$10m by Steve Jones April 27, 2023April 30, 2024
LGP repays loan to Canopy Growth after A$5m capital raise by Steve Jones March 27, 2023April 30, 2024
